The CASP8-652 6N del promoter polymorphism and breast cancer risk:: a multicenter study

被引:47
作者
Frank, Bernd [1 ,2 ]
Rigas, Sushila H. [3 ]
Bermejo, Justo Lorenzo [2 ]
Wiestler, Miriam [1 ,2 ]
Wagner, Kerstin [2 ]
Hemminki, Kari [2 ,4 ]
Reed, Malcolm W. [5 ]
Sutter, Christian [6 ]
Wappenschmidt, Barbara [7 ]
Balasubramanian, Sabapathy P. [5 ]
Meindl, Alfons
Kiechle, Marion
Bugert, Peter
Schmutzler, Rita K. [7 ]
Bartram, Claus R. [6 ]
Justenhoven, Christina
Ko, Yon-Dschun
Bruening, Thomas
Brauch, Hiltrud
Hamann, Ute
Pharoah, Paul P. D.
Dunning, Alison M.
Pooley, Karen A.
Easton, Douglas F.
Cox, Angela [3 ]
Burwinkel, Barbara [1 ,2 ]
机构
[1] Helmholtz Univ Grp Mol Epidemiol, German Canc Res Ctr, DKFZ, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany
[3] Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield, S Yorkshire, England
[4] Karolinska Inst, Ctr Family Med, Huddinge, Sweden
[5] Univ Sheffield, Sch Med, Acad Unit Surg Oncol, Sheffield, S Yorkshire, England
[6] Univ Heidelberg, Inst Human Genet, Heidelberg, Germany
[7] Univ Cologne, Ctr Clin, Dept Obstet & Gynaecol, Div Mol Gynaecooncol, Cologne, Germany
关键词
deletion; CASP8-652 6N del; Sp1 binding site; apoptosis; breast cancer risk;
D O I
10.1007/s10549-007-9752-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A recent study on an Asian population reported a six-nucleotide insertion-deletion polymorphism (-652 6N del) in the CASP8 promoter region to be strongly associated with a decreased risk of multiple types of cancer, including breast cancer (BC). Here, we investigate the effect of this deletion in four independent large European BC case-control studies, including data from a total of 7,753 cases and 7,921 controls. The combined per allele odds ratio (OR) was 0.97 (95% confidence interval (CI), 95% CI = 0.93-1.02). The present result indicates that the CASP8 -652 6N del variant has no significant effect on BC risk in Europeans.
引用
收藏
页码:139 / 144
页数:6
相关论文
共 21 条
[1]   Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk [J].
Baynes, Caroline ;
Healey, Catherine S. ;
Pooley, Karen A. ;
Scollen, Serena ;
Luben, Robert N. ;
Thompson, Deborah J. ;
Pharoah, Paul D. P. ;
Easton, Douglas F. ;
Ponder, Bruce A. J. ;
Dunning, Alison M. .
BREAST CANCER RESEARCH, 2007, 9 (02)
[2]   A common coding variant in CASP8 is associated with breast cancer risk [J].
Cox, Angela ;
Dunning, Alison M. ;
Garcia-Closas, Montserrat ;
Balasubramanian, Sabapathy ;
Reed, Malcolm W. R. ;
Pooley, Karen A. ;
Scollen, Serena ;
Baynes, Caroline ;
Ponder, Bruce A. J. ;
Chanock, Stephen ;
Lissowska, Jolanta ;
Brinton, Louise ;
Peplonska, Beata ;
Southey, Melissa C. ;
Hopper, John L. ;
McCredie, Margaret R. E. ;
Giles, Graham G. ;
Fletcher, Olivia ;
Johnson, Nichola ;
dos Santos Silva, Isabel ;
Gibson, Lorna ;
Bojesen, Stig E. ;
Nordestgaard, Borge G. ;
Axelsson, Christen K. ;
Torres, Diana ;
Hamann, Ute ;
Justenhoven, Christina ;
Brauch, Hiltrud ;
Chang-Claude, Jenny ;
Kropp, Silke ;
Risch, Angela ;
Wang-Gohrke, Shan ;
Schuermann, Peter ;
Bogdanova, Natalia ;
Doerk, Thilo ;
Fagerholm, Rainer ;
Aaltonen, Kirsimari ;
Blomqvist, Carl ;
Nevanlinna, Heli ;
Seal, Sheila ;
Renwick, Anthony ;
Stratton, Michael R. ;
Rahman, Nazneen ;
Sangrajrang, Suleeporn ;
Hughes, David ;
Odefrey, Fabrice ;
Brennan, Paul ;
Spurdle, Amanda B. ;
Chenevix-Trench, Georgia ;
Beesley, Jonathan .
NATURE GENETICS, 2007, 39 (03) :352-358
[3]  
Day N, 1999, BRIT J CANCER, V80, P95
[4]   Proliferation, cell cycle and apoptosis in cancer [J].
Evan, GI ;
Vousden, KH .
NATURE, 2001, 411 (6835) :342-348
[5]   Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant [J].
Frank, B ;
Hemminki, K ;
Wappenschmidt, B ;
Meindl, A ;
Klaes, R ;
Schmutzler, RK ;
Bugert, P ;
Untch, M ;
Bartram, CR ;
Burwinkel, B .
CARCINOGENESIS, 2006, 27 (03) :606-609
[6]  
Frank B, 2005, J NATL CANCER I, V97, P1012, DOI 10.1093/jnci/dji178
[7]   The biochemistry of apoptosis [J].
Hengartner, MO .
NATURE, 2000, 407 (6805) :770-776
[8]   Mammalian initiator apoptotic caspases [J].
Ho, PK ;
Hawkins, CJ .
FEBS JOURNAL, 2005, 272 (21) :5436-5453
[9]   Breast cancer: a candidate gene approach across the estrogen metabolic pathway [J].
Justenhoven, Christina ;
Hamann, Ute ;
Schubert, Falk ;
Zapatka, Marc ;
Pierl, Christiane B. ;
Rabstein, Sylvia ;
Selinski, Silvia ;
Mueller, Tina ;
Ickstadt, Katja ;
Gilbert, Michael ;
Ko, Yon-Dschun ;
Baisch, Christian ;
Pesch, Beate ;
Harth, Volker ;
Bolt, Hermann M. ;
Vollmert, Caren ;
Illig, Thomas ;
Eils, Roland ;
Dippon, Juergen ;
Brauch, Hiltrud .
BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (01) :137-149
[10]   The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism [J].
Liedtke, C ;
Gröger, N ;
Manns, MP ;
Trautwein, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) :27593-27604